PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1517375
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1517375
Global D-Dimer Testing Market Size Study, by Test Type, by Application, by End-use and Regional Forecasts 2022-2032
The Global D-Dimer Testing Market is valued at approximately USD 1.37 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2024-2032. The D-Dimer test is a critical diagnostic tool used to detect the presence of blood clots in the body. It measures levels of D-Dimer, a protein fragment produced when a blood clot dissolves, helping healthcare professionals assess the risk of clot formation and manage conditions such as stroke and other thrombotic disorders. This test is pivotal in diagnosing and monitoring various conditions, including DVT, PE, and DIC, by providing valuable insights into the likelihood of clot formation and aiding in the timely intervention and effective management of these disorders.
The increasing prevalence of blood clotting disorders, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC), is a significant factor driving market growth. The World Federation of Hemophilia reported that as of July 2022, 10,276 individuals with hemophilia were enrolled in 87 treatment centers across 40 countries. This highlights the growing need for effective diagnostic tools like the D-Dimer test. However, the market faces challenges such as a lack of standardization among D-Dimer assays and testing methodologies. This inconsistency can complicate the evaluation of patients and undermine the reliability of diagnostic conclusions. Furthermore, the emergence of aptamers as an alternative to antibodies for D-Dimer testing presents a significant shift in diagnostic methodologies. Aptamers offer cost-effective, stable, and rapidly produced solutions, enhancing the appeal of D-Dimer testing, particularly in resource-limited settings.
The D-Dimer testing market is segmented by test type, application, end-use, and region. The laboratory tests sub-segment dominated the market in 2022, reflecting their efficacy and reliability in providing accurate diagnostic insights. By application, the deep vein thrombosis (DVT) sub-segment was prominent, highlighting the critical role D-Dimer testing plays in diagnosing and managing DVT. The hospitals sub-segment led the market by end-use in 2022, emphasizing the central role hospitals play in diagnostic procedures and healthcare delivery.
The key regions considered for the Global D-Dimer Testing Market study include Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. In 2023, North America led the D-dimer testing market, underscoring the region's focus on proactive healthcare management. The widespread adoption of D-dimer testing across medical facilities has made it essential for evaluating thrombotic conditions and ruling out serious clotting disorders. This dominance highlights North America's commitment to advanced medical practices and a proactive approach to healthcare. The prevalence of D-dimer testing reflects the region's prioritization of early detection and intervention in thrombotic events, consistent with its broader healthcare ethos of preventative care. North America's significant share in the D-dimer testing market underscores its role as a leader in innovative medical technologies and diagnostic methodologies, setting a benchmark for other regions. On the other hand, Asia Pacific is poised to registered fastest growth over the forecast period 2024-2032.
Major market players included in this report are:
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers
- Abbott
- Biomerieux SA
- WERFEN
- HORIBA, Ltd.
- Quidel Corporation
- Diazyme Laboratories, Inc.
- Sekisui Diagnostics
- LumiraDx Limited
- Bio-Rad Laboratories
- Danaher Corporation
- Sysmex Corporation
- Hologic, Inc.
The detailed segments and sub-segment of the market are explained below:
Test Type:
- Point-of-Care Tests
- Laboratory Tests
Application:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Disseminated Intravascular Coagulation (DIC)
- Others
End-use:
- Hospitals
- Academic & Research Institutes
- Diagnostic Centers
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- RoMEA
Years considered for the study are as follows:
- Historical year - 2022
- Base year - 2023
- Forecast period - 2024 to 2032
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with Country level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
Table of Contents
Chapter 1. Global D-Dimer Testing Market Executive Summary
- 1.1. Global D-Dimer Testing Market Size & Forecast (2022-2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Test Type
- 1.3.2. By Application
- 1.3.3. By End-use
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
Chapter 2. Global D-Dimer Testing Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
Chapter 3. Global D-Dimer Testing Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Rise in incidents of blood clot disorders
- 3.1.2. Increasing demand for diagnostic testing in hospitals
- 3.1.3. Technological advancements in diagnostic tools
- 3.2. Market Challenges
- 3.2.1. Lack of standardization among D-Dimer assays
- 3.2.2. High costs associated with advanced diagnostic technologies
- 3.2.3. Inconsistent testing methodologies
- 3.3. Market Opportunities
- 3.3.1. Emergence of aptamers as an alternative to antibodies
- 3.3.2. Growing healthcare infrastructure in developing regions
- 3.3.3. Innovations in assay technologies
Chapter 4. Global D-Dimer Testing Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top investment opportunity
- 4.4. Top winning strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Global D-Dimer Testing Market Size & Forecasts by Test Type 2022-2032
- 5.1. Segment Dashboard
- 5.2. Global D-Dimer Testing Market: Test Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Point-of-Care Tests
- 5.2.2. Laboratory Tests
Chapter 6. Global D-Dimer Testing Market Size & Forecasts by Application 2022-2032
- 6.1. Segment Dashboard
- 6.2. Global D-Dimer Testing Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Deep Vein Thrombosis (DVT)
- 6.2.2. Pulmonary Embolism (PE)
- 6.2.3. Disseminated Intravascular Coagulation (DIC)
- 6.2.4. Others
Chapter 7. Global D-Dimer Testing Market Size & Forecasts by End-use 2022-2032
- 7.1. Segment Dashboard
- 7.2. Global D-Dimer Testing Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Hospitals
- 7.2.2. Academic & Research Institutes
- 7.2.3. Diagnostic Centers
- 7.2.4. Others
Chapter 8. Global D-Dimer Testing Market Size & Forecasts by Region 2022-2032
- 8.1. North America D-Dimer Testing Market
- 8.1.1. U.S. D-Dimer Testing Market
- 8.1.1.1. Test Type breakdown size & forecasts, 2022-2032
- 8.1.1.2. Application breakdown size & forecasts, 2022-2032
- 8.1.1.3. End-use breakdown size & forecasts, 2022-2032
- 8.1.2. Canada D-Dimer Testing Market
- 8.1.1. U.S. D-Dimer Testing Market
- 8.2. Europe D-Dimer Testing Market
- 8.2.1. UK D-Dimer Testing Market
- 8.2.2. Germany D-Dimer Testing Market
- 8.2.3. France D-Dimer Testing Market
- 8.2.4. Italy D-Dimer Testing Market
- 8.2.5. Spain D-Dimer Testing Market
- 8.2.6. Rest of Europe D-Dimer Testing Market
- 8.3. Asia-Pacific D-Dimer Testing Market
- 8.3.1. China D-Dimer Testing Market
- 8.3.2. India D-Dimer Testing Market
- 8.3.3. Japan D-Dimer Testing Market
- 8.3.4. Australia D-Dimer Testing Market
- 8.3.5. South Korea D-Dimer Testing Market
- 8.3.6. Rest of Asia Pacific D-Dimer Testing Market
- 8.4. Latin America D-Dimer Testing Market
- 8.4.1. Brazil D-Dimer Testing Market
- 8.4.2. Mexico D-Dimer Testing Market
- 8.4.3. Rest of Latin America D-Dimer Testing Market
- 8.5. Middle East & Africa D-Dimer Testing Market
- 8.5.1. Saudi Arabia D-Dimer Testing Market
- 8.5.2 South Africa D-Dimer Testing Market
- 8.5.3. Rest of Middle East & Africa D-Dimer Testing Market
Chapter 9. Competitive Intelligence
- 9.1. Key Company SWOT Analysis
- 9.2. Top Market Strategies
- 9.3. Company Profiles
- 9.3.1. Thermo Fisher Scientific Inc.
- 9.3.1.1. Key Information
- 9.3.1.2. Overview
- 9.3.1.3. Financial (Subject to Data Availability)
- 9.3.1.4. Product Summary
- 9.3.1.5. Market Strategies
- 9.3.2. F. Hoffmann-La Roche Ltd.
- 9.3.3. Siemens Healthineers
- 9.3.4. Abbott
- 9.3.5. Biomerieux SA
- 9.3.6. WERFEN
- 9.3.7. HORIBA, Ltd.
- 9.3.8. Quidel Corporation
- 9.3.9. Diazyme Laboratories, Inc.
- 9.3.10. Sekisui Diagnostics
- 9.3.11. LumiraDx Limited
- 9.3.12. Bio-Rad Laboratories
- 9.3.13. Danaher Corporation
- 9.3.14. Sysmex Corporation
- 9.3.15. Hologic, Inc.
- 9.3.1. Thermo Fisher Scientific Inc.
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
